Fundz

Icu Medical Completes The Acquisition Of Smiths Medical From Smiths Group Plc

PUBLIC · ICUIJan 06, 2022

Acquiring Company

ICU Medical

Acquired Company

Smiths Medical

San ClementeBiotechnologyHealth CareMedicalMedical Device

Description

ICU Medical Inc. (NASDAQ: ICUI) announced that it has completed its acquisition of Smiths Medical from Smiths Group plc (LSE: SMIN.L). The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical's existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at ICU Medical, and when

When ICU Medical changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day ICU Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ICU Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ICU Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ICU Medical

Location

San Clemente, California, United States

About

ICU Medical, Inc. operates in the medical technology industry, specializing in the development of innovative infusion systems and devices. The company primarily focuses on intravenous medication delivery and offers a range of products, including infusion pumps, IV access devices, and related technologies. ICU Medical serves healthcare providers globally, particularly in the United States, where it aims to enhance patient safety and clinical efficiency. The company has been strategically involved in expanding its presence in the market through acquisitions and developing advanced healthcare solutions to meet the growing demands in patient care. Its size is indicated by its registration on the Nasdaq Stock Market under the trading symbol 'ICUI'.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ICU Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ICU Medical's next move

Learn about Strategic plan

Frequently asked

Who acquired Smiths Medical?

Smiths Medical was acquired by ICU Medical, based in San Clemente. The deal was reported on January 6, 2022. ICU Medical, Inc. operates in the medical technology industry, specializing in the development of innovative infusion systems and devices. ICU Medical is publicly traded (ICUI) and operates in Biotechnology.

When did ICU Medical acquire Smiths Medical?

ICU Medical's acquisition of Smiths Medical was reported on January 6, 2022. ICU Medical Inc. (NASDAQ: ICUI) announced that it has completed its acquisition of Smiths Medical from Smiths Group plc (LSE: SMIN.L). The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Smiths Medical do?

ICU Medical US website homepage We bring technology to life The ICU Medical medical device portfolio incorporates established brands and strong positions in select segments of the Infusion Systems, Vascular Access and Vital Care markets in the USA. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.